fbpx

The Department of Bioengineering at UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system enables functional treatment imaging of diseases throughout the whole-body of a small animal while providing at the same time critical tissue characterization information.

According to Prof. Kenneth Hoyt, Director of the Small Animal Imaging Core facility: “The combination of 3D optical imaging with ultra-high-resolution microCT expands applications beyond traditional optical imaging. For instance, this Hybrid OI/CT system enables to pinpoint cancer deep into tissue and at the same time, can provide distinctive microvascular characteristics such as blood supply to determine whether tumors are prone to growth and metastasis. This provides prognostic value when monitoring early tumor response to neoadjuvant treatment.”

Prof. Frederik Beekman, CEO/CSO of MILabs adds:” We are excited that Prof. Hoyt’s team, a trend-setter in the disease and treatment effects of microvascular dysfunction, has selected Hybrid 3D OI/CT for his innovative research work. We hope to further collaborate with UT Dallas on future translational research by expanding his system with nuclear imaging capabilities such as PET and SPECT”

 

About the Department of Biomedical engineering at UT Dallas:

The Department of Bioengineering at UT Dallas integrates biomedical engineering with medicine and biology. Its research is focused on innovate medical solutions that will reduce health care costs, improve human health and increase the quality of life for all humankind.

More info at: https://be.utdallas.edu/bioengineering/about/

 

About MILabs B.V.

This Dutch company has a history of providing innovations to expand the applications of in-vivo imaging using PET, SPECT, Optical and X-ray CT. Available in any combination or as stand-alone systems, MILabs preclinical imaging modalities are globally recognized for being able to deliver the highest quality small-animal molecular, functional and anatomical images.

For more information, visit:  www.milabs.com or contact MILabs at [email protected]

Share on social media
Share on facebook
Share on twitter
Share on linkedin
Share on email

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. …

Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value …

Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs …

Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V …

Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” …

Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and …

Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of …

Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a …

Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress …

Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor …

Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting …

Read More →

The University of Southampton enters the field of Correlative In-Vivo Imaging by Acquiring MILabs 3D/4D Optical/CT

May 12, 2020, Southampton, UK – Utrecht, the Netherlands The Faculty of Medicine, University of …

Read More →
Scroll to Top